Pasithea Therapeutics (KTTA) Competitors $2.63 -0.04 (-1.50%) (As of 12/20/2024 05:30 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends KTTA vs. HCWB, AIM, SLGL, PMCB, AWH, WENA, IPA, IMNN, CRVO, and RLMDShould you be buying Pasithea Therapeutics stock or one of its competitors? The main competitors of Pasithea Therapeutics include HCW Biologics (HCWB), AIM ImmunoTech (AIM), Sol-Gel Technologies (SLGL), PharmaCyte Biotech (PMCB), Aspira Women's Health (AWH), ANEW Medical (WENA), ImmunoPrecise Antibodies (IPA), Imunon (IMNN), CervoMed (CRVO), and Relmada Therapeutics (RLMD). These companies are all part of the "pharmaceutical products" industry. Pasithea Therapeutics vs. HCW Biologics AIM ImmunoTech Sol-Gel Technologies PharmaCyte Biotech Aspira Women's Health ANEW Medical ImmunoPrecise Antibodies Imunon CervoMed Relmada Therapeutics HCW Biologics (NASDAQ:HCWB) and Pasithea Therapeutics (NASDAQ:KTTA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation. Does the media refer more to HCWB or KTTA? In the previous week, HCW Biologics' average media sentiment score of 0.00 equaled Pasithea Therapeutics'average media sentiment score. Company Overall Sentiment HCW Biologics Neutral Pasithea Therapeutics Neutral Which has more volatility and risk, HCWB or KTTA? HCW Biologics has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, Pasithea Therapeutics has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Does the MarketBeat Community favor HCWB or KTTA? HCW Biologics received 4 more outperform votes than Pasithea Therapeutics when rated by MarketBeat users. Likewise, 100.00% of users gave HCW Biologics an outperform vote while only 40.00% of users gave Pasithea Therapeutics an outperform vote. CompanyUnderperformOutperformHCW BiologicsOutperform Votes6100.00% Underperform VotesNo VotesPasithea TherapeuticsOutperform Votes240.00% Underperform Votes360.00% Is HCWB or KTTA more profitable? Pasithea Therapeutics has a net margin of 0.00% compared to HCW Biologics' net margin of -1,067.82%. Pasithea Therapeutics' return on equity of -81.57% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-1,067.82% -2,516.84% -132.95% Pasithea Therapeutics N/A -81.57%-74.31% Which has higher valuation & earnings, HCWB or KTTA? Pasithea Therapeutics has lower revenue, but higher earnings than HCW Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$3.50M4.86-$24.99M-$1.00-0.45Pasithea Therapeutics$20K166.48-$15.96MN/AN/A Do insiders & institutionals believe in HCWB or KTTA? 3.0% of HCW Biologics shares are held by institutional investors. Comparatively, 23.9% of Pasithea Therapeutics shares are held by institutional investors. 49.9% of HCW Biologics shares are held by insiders. Comparatively, 16.3% of Pasithea Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryPasithea Therapeutics beats HCW Biologics on 6 of the 11 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Pasithea Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KTTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KTTA vs. The Competition Export to ExcelMetricPasithea TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.33M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E RatioN/A10.5990.1317.20Price / Sales166.48196.061,117.09117.05Price / CashN/A57.1643.1037.85Price / Book0.125.094.784.78Net Income-$15.96M$151.83M$120.31M$225.60M7 Day Performance-0.75%-2.14%-1.92%-1.23%1 Month Performance-15.16%-4.56%13.65%0.46%1 Year Performance-66.98%8.87%28.34%15.24% Pasithea Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KTTAPasithea TherapeuticsN/A$2.63-1.5%N/A-55.1%$3.33M$20,000.000.003HCWBHCW Biologics0.4069 of 5 stars$0.36-0.3%N/A-60.4%$13.46M$3.50M-0.3640Gap DownAIMAIM ImmunoTech2.3673 of 5 stars$0.21-4.1%$2.75+1,209.5%-60.4%$13.39M$190,000.00-0.4720SLGLSol-Gel Technologies2.4245 of 5 stars$0.47-2.8%$5.00+973.2%-66.5%$12.98M$1.55M-1.3650PMCBPharmaCyte Biotech0.4217 of 5 stars$1.69-1.7%N/A-24.8%$12.98MN/A2.612Earnings ReportAWHAspira Women's Health1.218 of 5 stars$0.75+0.6%$4.40+483.6%-69.7%$12.57M$9.15M-0.62110Analyst ForecastWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpIPAImmunoPrecise Antibodies2.9227 of 5 stars$0.43+6.6%$5.00+1,062.8%-69.5%$12.40M$24.07M-0.5280News CoverageIMNNImunon2.3546 of 5 stars$0.84-0.5%$20.50+2,340.5%+9.2%$12.18M$500,000.00-0.4533Analyst ForecastNews CoverageGap UpCRVOCervoMed2.1768 of 5 stars$1.95+2.6%$42.00+2,053.8%-67.1%$12.03M$7.14M0.004Analyst DowngradeAnalyst RevisionHigh Trading VolumeRLMDRelmada Therapeutics4.19 of 5 stars$0.39+5.9%$4.25+993.1%-87.7%$11.73MN/A-0.1310Gap DownHigh Trading Volume Related Companies and Tools Related Companies HCW Biologics Alternatives AIM ImmunoTech Alternatives Sol-Gel Technologies Alternatives PharmaCyte Biotech Alternatives Aspira Women's Health Alternatives ANEW Medical Alternatives ImmunoPrecise Antibodies Alternatives Imunon Alternatives CervoMed Alternatives Relmada Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KTTA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
